Cellceutix Corp (OTC Pink - Current Information:CTIX)

Data as of Dec 19
 +0.005 / +0.11%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Cellceutix Corp. is a clinical stage biotechnology company, which focuses on discovering small molecule drugs for hard to treat diseases, including drug-resistant cancers, psoriasis, autism and inflammatory disease. It flagship compound, Kevetrin, is an anti-cancer drug which has demonstrated the ability in pre-clinical studies to regulate the p53 pathway and attack cancers. The company was founded by Krishna Kumar Menon and Leo Ehrlich in June 2007 and is headquartered in Beverly, MA.

Contact Information

Cellceutix Corp.
100 Cummings Center
Beverly Massachusetts 01915
P:(978) 236-8717
Investor Relations:



Individual stakeholders30.80%
Mutual fund holders--
Other institutional--

Top Executives

Leo EhrlichChairman, CEO, CFO, Secretary, Director & CAO
Krishna Kumar MenonPresident, Director & Chief Scientific Officer
William James AlexanderChief Operating Officer

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.